Dublin, 7th November 2019 - Eurofins, the international life sciences company, has officially opened its new Global Software Engineering Centre in the Leopardstown South County Business Park.
In January 2019, the company announced that the creation of 150 high-tech jobs with the establishment of its Global Software Engineering Centre in Dublin and it needed a suitable office footprint to accommodate the growing team. The company is on track to reach its 2019 goal of employing 60 staff, with further growth planned in 2020.
Commenting on the opening event, Claudius Masuch, Director of the Eurofins IT Solutions Engineering Office said: “Our recruitment team has been particularly busy, interviewing and selecting suitable candidates for the many roles we are creating here in Dublin. In our search for talent in the Digital and DevOps space, I am pleased to see that the quality of applicants, both from Ireland and abroad, is outstanding. Our recruitment drive will continue at increased speed throughout 2020 and we hope to have a full team in place in 2021.”
Martin Shanahan, CEO, IDA Ireland added:
“It’s great news that Eurofins are growing their presence here with the official opening of their Global Software Engineering centre in Leopardstown. High growth international companies continue to be attracted to Ireland due to the ease of access to a talented workforce. I wish Eurofins continued success in their Dublin operation.”
Eurofins was first established in Ireland in 2003 and currently employs 800 people in Ireland across laboratories in Dublin, Waterford and Cork, in the area of clinical diagnostics, biopharma product testing, food and beverage testing as well as environmental testing, and corporate functions based in Dublin.
The growing IT team in Dublin is focusing on DevOps, virtualisation and cloud strategy, driving quality and software engineering best practice as part of the 1,500-strong Eurofins global software development teams in the US, Europe and India.
Eurofins provides a unique range of analytical testing services to clients across multiple industries. The Group is a scientific leader in food, environment, pharmaceutical and cosmetics products testing and in agroscience CRO services. It is also one of the global independent market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, CDMO, advanced material sciences and for supporting clinical studies. In addition, Eurofins is one of the leading global emerging players in specialty clinical diagnostic testing.
All Eurofins job openings can be explored on the Eurofins Career Pages: https://careers.eurofins.com/ie/jobs?countryId=ie&deptid=5
Eurofins Scientific through its subsidiaries (hereinafter sometimes “Eurofins” or “the Group”) believes it is a scientific leader in food, environment, pharmaceutical and cosmetics products testing and in agroscience CRO services. It is also one of the global independent market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, CDMO, advanced material sciences and for supporting clinical studies. In addition, Eurofins is one of the leading global emerging players in specialty clinical diagnostic testing. With about 45,000 staff in more than 800 laboratories across 47 countries, Eurofins offers a portfolio of over 200,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products, as well as for innovative clinical diagnostic. The Group objective is to provide its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients’ increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.
The shares of Eurofins Scientific are listed on the Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA.
Group Head of Communications, Eurofins
Assistant Media Relations Executive, IDA Ireland